Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

9.0K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.0K
Cancer Therapies02:49

Cancer Therapies

10.3K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
10.3K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Dysregulated miRNA Expression and Androgen Receptor Loss in Racially Distinct Triple-Negative Breast Cancer.

International journal of molecular sciences·2025
Same author

Meta-analysis of the Mesenchymal Stem Cells Immortalization Protocols: A Guideline for Regenerative Medicine.

Current stem cell research & therapy·2024
Same author

MiRNAs Action and Impact on Mitochondria Function, Metabolic Reprogramming and Chemoresistance of Cancer Cells: A Systematic Review.

Biomedicines·2023
Same author

MiR-150-5p Overexpression in Triple-Negative Breast Cancer Contributes to the In Vitro Aggressiveness of This Breast Cancer Subtype.

Cancers·2022
Same author

COVID-19: The question of genetic diversity and therapeutic intervention approaches.

Genetics and molecular biology·2022
Same author

MiR-182-5p Modulates Prostate Cancer Aggressive Phenotypes by Targeting EMT Associated Pathways.

Biomolecules·2022

相关实验视频

Updated: Feb 28, 2026

Studying Triple Negative Breast Cancer Using Orthotopic Breast Cancer Model
09:29

Studying Triple Negative Breast Cancer Using Orthotopic Breast Cancer Model

Published on: March 20, 2020

19.0K

在三阴性乳腺癌中基于非编码RNA的治疗策略:系统性审查

Giovana Prado Scaratti1,2, Inaiê Maiala de Almeida Miranda1,2, Emanuelle Nunes-Souza1,2

  • 1Instituto de Pesquisa Pelé Pequeno Príncipe, Av. Silva Jardim, 1632, Curitiba 80250-060, Brazil.

International journal of molecular sciences
|February 27, 2026
PubMed
概括

非编码RNAs (ncRNAs) 在治疗三阴性乳腺癌 (TNBC) 方面表现有前途. 在临床前模型中准特定的ncRNA抑制了瘤生长和转移,提供了新的治疗途径.

关键词:
这是一个微型RNA.美国TNBC电视台圆形的RNARNA是一个圆形的RNA.长非编码RNA是什么意思没有编码的RNA.临床前研究 临床前研究治疗疗法治疗疗法治疗疗法

更多相关视频

Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells
07:23

Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells

Published on: May 30, 2025

1.2K
Monitoring of Nanodrug Accumulation in Murine Breast Cancer Metastases
09:48

Monitoring of Nanodrug Accumulation in Murine Breast Cancer Metastases

Published on: August 23, 2024

823

相关实验视频

Last Updated: Feb 28, 2026

Studying Triple Negative Breast Cancer Using Orthotopic Breast Cancer Model
09:29

Studying Triple Negative Breast Cancer Using Orthotopic Breast Cancer Model

Published on: March 20, 2020

19.0K
Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells
07:23

Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells

Published on: May 30, 2025

1.2K
Monitoring of Nanodrug Accumulation in Murine Breast Cancer Metastases
09:48

Monitoring of Nanodrug Accumulation in Murine Breast Cancer Metastases

Published on: August 23, 2024

823

科学领域:

  • 在瘤学瘤学.
  • 分子生物学分子生物学
  • 在RNA治疗方面,RNA疗法.

背景情况:

  • 三重阴性乳腺癌 (TNBC) 呈现出显著的异质性,限制了目前的向治疗成功.
  • 大多数TNBC患者依赖化疗,突出了需要新的治疗策略.
  • 非编码RNAs (ncRNAs) 正在成为TNBC的潜在治疗点.

研究的目的:

  • 系统地审查临床前研究,评估在TNBC中准ncRNA的治疗潜力.
  • 为了确定特定的ncRNA作为TNBC治疗的可操作目标.
  • 在临床前TNBC模型中评估ncRNA调制的疗效.

主要方法:

  • 对35项临床前研究 (2020-2025) 关于TNBC中ncRNA向的系统审查.
  • 使用体内瘤模型评估治疗反应的研究分析.
  • 评估各种ncRNA调制技术 (miRNA模仿,对抗Rs,ASOs,shRNAs,siRNAs) 和传递系统 (纳米粒子,外体).

主要成果:

  • 在TNBC中确定了28个特定的ncRNA作为可操作的目标.
  • 在临床前模型中,ncRNA调制始终抑制瘤生长和转移.
  • 准ncRNAs恢复了对标准化疗剂的敏感性.

结论:

  • 临床前证据支持基于ncRNA的疗法作为TNBC治疗的有希望的策略.
  • 准ncRNAs提供了一种新的方法来克服TNBC的治疗局限性.
  • 进一步开发基于ncRNA的疗法可以显著提升TNBC治疗选择.